HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pars planitis in children: epidemiologic, clinical, and therapeutic characteristics.

AbstractPURPOSE:
To report the demographics and clinical characteristics, therapy logarithm, and prognosis of children with pars planitis.
PATIENTS AND METHODS:
The medical records were reviewed of all patients diagnosed with pars planitis between June 1995 and December 2005 in the Department of Pediatric Ophthalmology at Hospital Universitario La Paz, Madrid, Spain. A retrospective, descriptive, and longitudinal study of 30 eyes in 16 children was performed.
RESULTS:
Pars planitis was bilateral in 87.5% and more frequent in males (68.8%). Average age at onset was 9.2 years. The main ophthalmologic findings recorded were snowballs (96.7%) and vitritis (93.3%). Cataract formation was the most prevalent complication (36.7%). Mean initial and final best-corrected visual acuities were 0.640 and 0.840, respectively. Periocular corticosteroids were used in 33.3% of cases and cryotherapy or laser photocoagulation in 16.7%. Complications requiring surgical management occurred in 4 eyes (13.3%).
CONCLUSION:
Pars planitis treated with adequate medical and surgical procedures has a good prognosis in most cases.
AuthorsRicardo Romero, Jesus Peralta, Elena Sendagorta, Jose Abelairas
JournalJournal of pediatric ophthalmology and strabismus (J Pediatr Ophthalmol Strabismus) 2007 Sep-Oct Vol. 44 Issue 5 Pg. 288-93 ISSN: 0191-3913 [Print] United States
PMID17913171 (Publication Type: Journal Article)
Chemical References
  • Glucocorticoids
Topics
  • Adolescent
  • Age of Onset
  • Child
  • Cryotherapy
  • Female
  • Glucocorticoids (therapeutic use)
  • Humans
  • Laser Coagulation
  • Male
  • Pars Planitis (diagnosis, epidemiology, therapy)
  • Prognosis
  • Retrospective Studies
  • Sex Distribution
  • Spain (epidemiology)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: